62 related articles for article (PubMed ID: 16020431)
1. Sex Hormones in Lymphedema.
Morfoisse F; Zamora A; Marchaud E; Nougue M; Diallo LH; David F; Roussel E; Lacazette E; Prats AC; Tatin F; Garmy-Susini B
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33573286
[TBL] [Abstract][Full Text] [Related]
2. 17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation.
Bendale DS; Karpe PA; Chhabra R; Shete SP; Shah H; Tikoo K
Br J Pharmacol; 2013 Oct; 170(4):779-95. PubMed ID: 23826814
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency.
Korzick DH; Lancaster TS
Pflugers Arch; 2013 May; 465(5):669-85. PubMed ID: 23525672
[TBL] [Abstract][Full Text] [Related]
4. Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.
Labandeira-Garcia JL; Rodriguez-Pallares J; Rodríguez-Perez AI; Garrido-Gil P; Villar-Cheda B; Valenzuela R; Guerra MJ
Am J Neurodegener Dis; 2012; 1(3):226-44. PubMed ID: 23383395
[TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.
Farr JN; Khosla S; Miyabara Y; Miller VM; Kearns AE
J Clin Endocrinol Metab; 2013 Feb; 98(2):E249-57. PubMed ID: 23322818
[TBL] [Abstract][Full Text] [Related]
6. Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.
Labandeira-Garcia JL; Rodriguez-Pallares J; Villar-Cheda B; Rodríguez-Perez AI; Garrido-Gil P; Guerra MJ
Aging Dis; 2011 Jun; 2(3):257-74. PubMed ID: 22396877
[TBL] [Abstract][Full Text] [Related]
7. Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women.
Miner JA; Martini ER; Smith MM; Brunt VE; Kaplan PF; Halliwill JR; Minson CT
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1716-22. PubMed ID: 21856917
[TBL] [Abstract][Full Text] [Related]
8. A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.
Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
Contraception; 2010 Oct; 82(4):366-72. PubMed ID: 20851231
[TBL] [Abstract][Full Text] [Related]
9. Estradiol is a potent protective, restorative, and trophic factor after brain injury.
Brown CM; Suzuki S; Jelks KA; Wise PM
Semin Reprod Med; 2009 May; 27(3):240-9. PubMed ID: 19401955
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of estrogens following ischemic stroke.
Suzuki S; Brown CM; Wise PM
Front Neuroendocrinol; 2009 Jul; 30(2):201-11. PubMed ID: 19401209
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex sensitivity varies during the rat estrous cycle: role of gonadal steroids.
Goldman RK; Azar AS; Mulvaney JM; Hinojosa-Laborde C; Haywood JR; Brooks VL
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1419-26. PubMed ID: 19261912
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and mechanisms of vascular protection.
Xing D; Nozell S; Chen YF; Hage F; Oparil S
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):289-95. PubMed ID: 19221203
[TBL] [Abstract][Full Text] [Related]
13. Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1630-7. PubMed ID: 18281378
[TBL] [Abstract][Full Text] [Related]
14. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.
Suzuki S; Brown CM; Dela Cruz CD; Yang E; Bridwell DA; Wise PM
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6013-8. PubMed ID: 17389368
[TBL] [Abstract][Full Text] [Related]
15. Women, hormones, and clinical trials: a beginning, not an end.
Miller VM; Clarkson TB; Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Naftolin F; Santoro N
J Appl Physiol (1985); 2005 Aug; 99(2):381-3. PubMed ID: 16020431
[No Abstract] [Full Text] [Related]
16. Comments on Women, hormones, and clinical trials: a beginning, not an end.
Minson CT; Kaplan P; Meendering JR; Torgrimson BN; Miller NP
J Appl Physiol (1985); 2006 Jan; 100(1):373. PubMed ID: 16357092
[No Abstract] [Full Text] [Related]
17. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
Clarkson TB; Meléndez GC; Appt SE
Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
19. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
Sherwin BB
Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
